Impact of primary staging with fibroblast activation protein specific enzyme inhibitor (FAPI)-PET/CT on radio-oncologic treatment planning of patients with esophageal cancer
Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness in radio...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
5 October 2020
|
| In: |
Molecular imaging & biology
Year: 2020, Volume: 22, Issue: 6, Pages: 1495-1500 |
| ISSN: | 1860-2002 |
| DOI: | 10.1007/s11307-020-01548-y |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11307-020-01548-y |
| Author Notes: | J. Ristau, F.L. Giesel, M.F. Haefner, F. Staudinger, T. Lindner, A. Merkel, J. Schlittenhardt, C. Kratochwil, P.L. Choyke, K. Herfarth, J. Debus, U. Haberkorn, S.A. Koerber |
| Summary: | Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness in radiotherapy planning as a first clinical analysis. |
|---|---|
| Item Description: | Gesehen am 18.10.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1860-2002 |
| DOI: | 10.1007/s11307-020-01548-y |